<?xml version="1.0" encoding="UTF-8"?>
<document id="29112861">
	<sentence id="s1" text="Although disruption of the CDKN2A (INK4A/ARF) locus has been reported in end-stage disease, information is lacking on the status of this key tumor suppressor gene in pleural lesions preceding mesothelioma.">
		<entity id="s1.e1" charOffset="27-33"
			type="GENE" text="CDKN2A" ontology_id="1029"/>
		<entity id="s1.e2" charOffset="141-146"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="true"/>
	</sentence>
	<sentence id="s2" text="We show that hypermethylation of p16/Ink4a and p19/Arf in CNT- and asbestos-induced inflammatory lesions precedes mesothelioma; this results in silencing of Cdkn2a (Ink4a/Arf) and loss of p16 and p19 protein, consistent with epigenetic alterations playing a gatekeeper role in cancer.">
		<entity id="s2.e1" charOffset="157-163"
			type="GENE" text="Cdkn2a" ontology_id="1029"/>
		<entity id="s2.e2" charOffset="277-283"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="true"/>
	</sentence>
</document>
